We speculated that G‐Rg5 could exert anti‐osteosarcoma effects by binding to the p110α catalytic subunit of PI3K and contribute to the regulation of downstream targets that involve in PI3K/Akt signaling pathway. Here, PIK3CA is linked to osteosarcoma.